Latest Royalties News

Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

AFT Pharmaceuticals secures tentative FDA approval for Scomara cream to treat rare facial tumours but faces a US launch delay due to orphan drug exclusivity. The approval bolsters prospects in other markets where AFT expects competitive advantages.

Everest Metals has obtained a critical mining lease for its Revere Gold Project in WA, marking a major step from exploration to development with a 260,780-ounce maiden resource and ongoing approvals.

Reward Minerals has validated high-grade gold and copper mineralisation at its Mountain Pond Project in Newfoundland, advancing towards maiden drilling at the Jackpot Prospect with strong soil sampling at nearby Bingo.

True North Copper (ASX:TNC) has agreed to sell its Bundarra Copper Project to Tec Minerals, securing A$500,000 cash, A$1 million equity in Tec Minerals, and a 1% Net Smelter Royalty, as it sharpens focus on its Mt Oxide and Cloncurry copper developments.

Starpharma Holdings is raising approximately $32 million through a fully underwritten 1-for-7.5 renounceable entitlement offer priced at $0.57 per share, discounting the stock by 25%. Proceeds will fund the DEP HER2-Lu Phase 1 trial and expand its dendrimer-based oncology pipeline.

Dimerix has acquired DMX-652, a Phase 2-ready oral drug candidate targeting acute kidney injury, expanding its renal disease portfolio. The acquisition includes patent rights, an FDA-approved trial protocol, and funding to initiate clinical development.

Wia Gold advances its Kokoseb Gold Project with strong drilling results revealing new underground targets, a $92 million capital raise, and ongoing feasibility study progress.

Starpharma launches a fully underwritten $32 million entitlement offer to fund the Phase 1 trial of its DEP® HER2-Lutetium radiopharmaceutical and accelerate its targeted oncology asset development.

Core Lithium has kicked off open pit mining at Grants and underground development at BP33, backed by strong cash reserves and strategic asset divestment plans.

Amplitude Energy reported record FY26 production of 27.6 PJe and revenue of $285.8 million, boosted by strong gas prices and operational gains. The company’s East Coast Supply Project (ECSP) progresses with the Artisan gas field acquisition and upcoming drilling at Juliet and Annie wells.